| 35.95 Delayed Data As of Oct 18 |  -0.65 / -1.78%Today’s Change | 10.41 Today|||52-Week Range 38.75 | +189.45% Year-to-Date |
| Why Did the Market Whack This IPO? Oct 14 / MotleyFool.com - Paid Partner Content |
| Previous close | 36.60 |
| Today’s open | 36.89 |
| Day’s range | 35.60 - 38.75 |
| Volume | 3,644,756 |
| Average volume (3 months) | 1,412,910 |
| Market cap | $3.1B |
| Earnings growth (last year) | -38.51% |
| Earnings growth (this year) | +214.87% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -48.60% |
| P/E ratio | 78.2 |
| Price/Sales | 99.33 |
| Price/Book | 30.09 |
| Today’s change | Today’s % change | |
|---|---|---|
| MORMorphoSys AG | +0.20 | +0.73% |
| ALLOAllogene Therapeutic... | -0.41 | -1.48% |
| BPMCBlueprint Medicines ... | +0.36 | +0.48% |
| NKTRNektar Therapeutics | -0.50 | -2.81% |
| Next reporting date | December 2, 2019 |
| EPS forecast (this quarter) | $0.15 |
| Annual revenue (last year) | $16.1M |
| Annual profit (last year) | -$54.5M |
| Net profit margin | -337.32% |
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Pasadena, California |
